URSULA KNIGHT: Open Payments
NPI 1124576707 · MOSS POINT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 20 payments from 13 companies in 2025. Trend: 2023 $595 · 2024 $599 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $142 |
| ABBVIE INC. | 5 | $83 |
| Corcept Therapeutics | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| COLOPLAST CORP | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: Ozempic, VRAYLAR, UBRELVY, Korlym, AIRSUPRA, XIFAXAN, Titan, Cologuard Collection Kit.
Industry payments across MS — which companies pay providers there.
